TRUMP SIGNS ORDERS TO ENCOURAGE DRUG MANUFACTURING AND RESTRICT RESEARCH THAT ENHANCES PATHOGENS
U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.
Trump signed the order during an event in the Oval Office in which he also told reporters he would make announcements in the coming weeks on the cost of drugs as well as pharmaceutical tariffs.
Last month, the Trump administration launched probes into imports of pharmaceuticals and semiconductors as it looks to impose tariffs on both sectors on grounds that extensive reliance on foreign production of medicine and chips is a national security threat.
On Monday Trump also signed an order that bans federal funding for gain-of-function research that typically enhances pathogens.
